Clinical Trials Directory

Trials / Unknown

UnknownNCT03561623

Spinal Cord Gray Matter Imaging in Post Polio Syndrome

Quantitative Spinal Cord Gray Matter Imaging in Post Polio Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a longitudinal, observational study with the aims of comparing spinal cord gray matter areas in patients with Post-Polio Syndrome to age and sex matched healthy control subjects and to correlate atrophy with metrics of clinical disability.

Detailed description

Post-Polio syndrome (PPS) is characterised by new muscle weakness, pain, and fatigue several years to decades after the acute polio infection. Pathomechanisms are not yet fully understood. This is a longitudinal, observational study. The aims are (a) to detect spinal cord gray (and possibly) white matter atrophy in patients with Post Polio Syndrome in comparison to healthy age and sex matched control subjects both cross-sectionally and longitudinally and (b) to correlate spinal cord gray and white matter atrophy to metrics of clinical disability. Investigators will assess 20 patients with Post-Polio syndrome and 20 control subjects at baseline and 48 weeks by MRI and clinically including quantitative muscle strength assessments.

Conditions

Interventions

TypeNameDescription
OTHERmagnetic resonance (MR) ImagingMRI of spinal cord and brain
OTHERquantitative muscle force assessmentquantitative assessment of muscle force

Timeline

Start date
2017-05-22
Primary completion
2022-10-01
Completion
2022-10-01
First posted
2018-06-19
Last updated
2020-06-24

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03561623. Inclusion in this directory is not an endorsement.